Alithea Genomics
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Corniche Rd Serine Building 8 L -2, Epal...Website
www.alitheagenomics.comRevenue
$8.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Alithea Genomics
Alithea Genomics is a Swiss-based biotechnology firm specializing in innovative RNA sequencing solutions that simplify large-scale gene expression analysis. The company develops highly efficient transcriptomics technologies supporting drug discovery, biomarker identification, and fundamental research. Offerings include advanced library preparation tools and bioinformatics support for research institutions and commercial labs.Explore more
Alithea Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alithea Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Alithea Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Alithea Genomics recently announced quarterly report
Funding: Get notified immidiatlly once Alithea Genomics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Alithea Genomics
Product Launch: Get notified when Alithea Genomics launches new products
Check if Alithea Genomics has recently received funding, and reach out quickly before it becomes old news!
Check out if Alithea Genomics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Alithea Genomics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Alithea Genomics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Alithea Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Alithea Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Alithea Genomics.
Alithea Genomics financials insights
Gather financial insights about Alithea Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$1M
2024
Angel/Seed
$3.2M
2026
Unspecified
$8.8M
Alithea Genomics Tech Stack
A closer look at the technologies used by Alithea Genomics
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Event
will be attending the European Human Genetics Conference 2023 conference as an exhibitor. The event will occur from June 10 to June 13, 2023.
Funding
Alithea Genomics News & Media
Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery
LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea has launched Full-Length DRUG-seq, which combines massive sample multiplexing, extraction-free workflow and full transcript coverage.Alithea Genomics Closes CHF 2.8 Million in Seed Financing Extension Led by Novalis Biotech
LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea Genomics closed a CHF 2.8 million ($3.2 million) seed extension led by the Novalis Biotech Acceleration fund and included TechU Ventures.EPFL spin-off Alithea Genomics brings RNA sequencing into the age of big data | Science
EPFL spin-off Alithea Genomics has developed a system that allows scientists to easily tag bulk RNA samples with molecular barcodes so they can be processed by the hundreds in one single tube. The technology promises to dramatically shorten and streamline sample preparation for RNA sequencing, which will enable new applications for this technology, such as biomarker discovery and drug development. RNA sequencing is becoming a key part of the process of developing new drugs andAlithea Genomics Raises CHF 1 Million in Seed Financing Round Led by Novalis Biotech
LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea Genomics, a fast-growing leader in RNA sequencing and transcriptomics analysis, has closed a CHF 1 million seed financing.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Alithea Genomics
Sign Up For FreeTo access detailed company insights
Alithea Genomics is a Swiss-based biotechnology firm specializing in innovative RNA sequencing solutions that simplify large-scale gene expression analysis. The company develops highly efficient transcriptomics technologies supporting drug discovery, biomarker identification, and fundamental research. Offerings include advanced library preparation... Read More
